Please wait a minute...
文章检索
预防医学  2022, Vol. 34 Issue (5): 519-524    DOI: 10.19485/j.cnki.issn2096-5087.2022.05.020
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
墨玉县居民代谢性疾病患病调查
呼聪慧1, 苏银霞2, 阿力米热·阿布迪热依木1, 姚华2
1.新疆医科大学公共卫生学院,新疆 乌鲁木齐 830000;
2.新疆医科大学,新疆 乌鲁木齐 830000
Investigation on the prevalence of metabolic diseases among residentsin Moyu County
HU Conghui1, SU Yinxia2, Alimire Abudireyimu1, YAO Hua2
1. School of Public Health, Xinjiang Medical University, Urumqi, Xinjiang 830000, China;
2. Xinjiang Medical University, Urumqi, Xinjiang 830000, China
全文: PDF(986 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解新疆和田地区墨玉县居民代谢性疾病患病情况,为制定代谢性疾病防控策略提供依据。方法 通过医院体检病历系统收集2020年墨玉县≥18岁居民的人口学信息、实验室检测和肝胆B超检测资料,分析墨玉县居民肥胖、高血压、糖尿病、血脂异常和脂肪肝等代谢性疾病患病情况。采用多分类logistic回归模型分析代谢性疾病的影响因素。结果 调查281 803人,其中男性129 549人,占49.97%;女性152 254人,占54.03%。年龄MQR)为37.00(22.00)岁。患代谢性疾病134 306例,患病率为47.66%;其中,肥胖、高血压、血脂异常、脂肪肝和糖尿病的患病率分别为25.72%、24.77%、12.30%、12.05%和5.49%,均随年龄增长呈上升趋势(χ2趋势=11 243.73、14 086.41、2 109.70、6 631.22、2 011.15,均P<0.001)。患1种代谢性疾病73 811例,占26.19%;患多种代谢性疾病60 495例,占21.47%。多分类logistic回归分析结果显示,性别(OR=0.870;0.796)、年龄(OR:1.703~8.701;2.952~18.846)、婚姻状况(OR:1.397~1.845;1.460~2.377)、文化程度(OR:0.891~0.937;0.920~0.924)、职业(OR:1.177~1.270;1.114~2.099)、家族史(OR=1.136;1.390)、饮酒频率(OR:2.038;1.395~2.574)和中心性肥胖(OR=3.448;14.352)与患1种和多种代谢性疾病有统计学关联。结论 墨玉县居民代谢性疾病患病率较高。男性、中老年人、文化程度低和不健康生活方式可能增加代谢性疾病的患病风险。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
呼聪慧
苏银霞
阿力米热·阿布迪热依木
姚华
关键词 代谢性疾病肥胖高血压糖尿病血脂异常    
AbstractObjective To investigate the prevalence of metabolic diseases among residents in Moyu County, Hotan Prefecture, Xinjiang Uygur Autonomous Region, so as to provide the evidence for developing the control strategy for metabolic diseases. Methods The demographic features, laboratory examinations and B-mode ultrasonographic examinations of the liver and gall bladder were collected from residents at ages of 18 years and older in Moyu County through the hospital-based medical records system. The prevalence of metabolic diseases was estimated, including obesity, hypertension, diabetes, dyslipidemia and fatty liver, and the factors affecting the development of metabolic diseases were identified using a multinomial logistic regression model. Results Totally 281 803 residents were included in the study, including 129 549 men ( 49.97% ) and 152 254 women ( 54.03% ) and with a median age of 37.00 years ( interquartile range, 22.00 years ). The overall prevalence of metabolic diseases was 47.66%, and the prevalence rates of obesity, hypertension, dyslipidemia, fatty liver and diabetes were 25.72%, 24.77%, 12.30%, 12.05% and 5.49%, respectively, which appeared a tendency towards a rise with age ( χ2trend = 11 243.73, 14 086.41, 2 109.70, 6 631.22, and 2 011.15, all P<0.001 ). There were 73 811 residents suffering from one metabolic disease (26.19%), and 60 495 residents with two and more metabolic diseases ( 21.47% ). Multinomial logistic regression analysis showed that gender ( OR=0.870; 0.796 ), age ( OR: 1.703-8.701; 2.952-18.846 ), marital status ( OR: 1.397-1.845; 1.460-2.377 ) educational level ( OR: 0.891-0.937; 0.920-0.924 ), occupation ( OR: 1.177-1.270; 1.114-2.099), family history ( OR=1.136; 1.390), drinking frequency ( OR: 2.038; 1.395-2.574 ) and central obesity ( OR=3.448; 14.352 ) were factors affecting the development of one or more metabolic diseases. Conclusion The prevalence of metabolic diseases is high among residents in Moyu County. Men, the elderly, a low education level and unhealthy lifestyles may increase the risk of metabolic diseases.
Key wordsmetabolic disease    obesity    hypertension    diabetes    dyslipidemia
收稿日期: 2021-11-02      修回日期: 2022-03-04     
中图分类号:  R589  
基金资助:国家自然科学基金项目(81960608)
作者简介: 呼聪慧,硕士研究生在读
通信作者: 姚华,E-mail:yaohua01@sina.com   
引用本文:   
呼聪慧, 苏银霞, 阿力米热·阿布迪热依木, 姚华. 墨玉县居民代谢性疾病患病调查[J]. 预防医学, 2022, 34(5): 519-524.
HU Conghui, SU Yinxia, Alimire Abudireyimu, YAO Hua. Investigation on the prevalence of metabolic diseases among residentsin Moyu County. Preventive Medicine, 2022, 34(5): 519-524.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2022.05.020      或      https://www.zjyfyxzz.com/CN/Y2022/V34/I5/519
[1] 吴娜娜. 不同体质与慢性代谢性疾病相关性研究进展[J].中医药临床杂志,2018,30(9):1771-1775.
WU N N.Research progress of correlation between different physique and chronic metabolic diseases[J].Clin J Tradit Chin Med,2018,30(9):1771-1775.
[2] 陈莹,梅勇.荆门某化工厂职工代谢性疾病的调查分析[J].中国卫生产业,2019,16(22):185-187.
CHEN Y,MEI Y.Investigation and analysis of metabolic diseases among workers in a chemical plant in Jingmen[J].Chin Health Ind,2019,16(22):185-187.
[3] 郭佩,李春君,张莉,等.天津市成人代谢性疾病共病患病率及其影响因素[J].职业与健康,2021,37(22):3061-3066,3071.
GUO P,LI C J,ZHANG L,et al.Prevalence of metabolic disease multimorbidity and its influencing factors among adults in Tianjin[J].Occup Health,2010,37(22):3061-3066,3071.
[4] HUANG Y,KARURANGA S,MALANDA B,et al.Call for data contribution to the IDF diabetes atlas 9th edition 2019[J].Diabetes Res Clin Pract,2018,140:351-352.
[5] 诸骏仁,高润霖,赵水平,等.中国成人血脂异常防治指南(2016年修订版)[J].中华健康管理学杂志,2017,11(1):7-28.
ZHU J R,GAO R L,ZHAO S P,et al.2016 Chinese guideline for the management of dyslipidemia in adults[J].Chin J Health Manag,2017,11(1):7-28.
[6] 国家卫生健康委员会疾病预防控制局,中华心血管病杂志编辑委员会,国家心血管病中心,等.中国高血压健康管理规范(2019)[J].中华心血管病杂志,2020,48(1):10-46.
Bureau of Disease Control and Prevention,National Health Commission,Editorial Board of Chinese Journal of Cardiovascular Diseases,National Cardiovascular Center,et al.National guideline for hypertension management in China(2019)[J].Chin J Cardiol,2020,48(1):10-46.
[7] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)(上)[J].中华糖尿病杂志,2021,13(4):315-409.
Chinese Diabetes Society.Guideline for the prevention and treatment of type 2 diabetes mellitus in China(2020 edition)[J].Chin J Diabetes Mellit,2021,13(4):315-409.
[8] 中华人民共和国卫生部.中国成人超重和肥胖症预防控制指南[M].北京:人民卫生出版社,2006.
Ministry of Health of the People's Republic of China.Guidelines for the prevention and control of overweight and obesity in adults in China[M].Beijing:People's Medical Publishing House,2006.
[9] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018年更新版)[J].实用肝脏病杂志,2018,21(2):177-186.
Liver and Alcoholic Liver Disease,Chinese Society of Hepatology,Chinese Medical Association,Fatty Liver Expert Committee,Chinese Medical Doctor Association.Guidelines of prevention and treatment for nonalcoholic fatty liver disease:a 2018 update[J].J Pract Hepatol,2018,21(2):177-186.
[10] 中华医学会健康管理学分会,中华健康管理学杂志编委会.健康体检基本项目专家共识[J].中华健康管理学杂志,2014,8(2):81-90.
Chinese Medical Association Health Management Association,Editorial Board of Chinese Journal of Health Management.Expert consensus on basic items of health checkup[J].Chin J Health Manag,2014,8(2):81-90.
[11] 李文丽,苏银霞,诸葛瑾慧,等.新疆新源县居民慢性病患病现状及影响因素[J].职业与健康,2021,37(5):639-643.
LI W L,SU Y X,ZHUGE J H,et al.Prevalence and influencing factors of chronic diseases among residents in Xinyuan County of Xinjiang[J].Occup Health,2021,37(5):639-643.
[12] 张国珍,田恬,裴华莲,等.新疆和田地区墨玉县35~74岁人群睡眠状况与慢性病共病关系的研究[J].新疆医科大学学报,2019,42(10):1244-1248,1254.
ZHANG G Z,TIAN T,PEI H L,et al.Study of the relationship between the sleep status and chronic comorbidities among people aged 35-74 years of Moyu,Hetian,Xinjiang[J].J Xinjiang Med Univ,2019,42(10):1244-1248,1254.
[13] 迪娜·木合亚提,吕梅霞,菲罗娜·帕尔哈提,等.2018年和田县农村居民体质指数、腰围与血脂的相关性分析[J].预防医学论坛,2021,27(1):10-12,16.
[14] 卡米拉·牙尔买买提.新疆和田地区维吾尔族居民健康素养及生活方式调查分析[D].乌鲁木齐:新疆医科大学,2019.
[15] 段晓阳,李敏,祁志刚,等.高血压家族史和行为危险因素聚集与高血压患病关系[J].中国公共卫生,2022,38(2):172-176.
DUAN X Y,LI M,QI Z G,et al.The relationship between family history of hypertension and behavioral risk factor aggregation and the prevalence of hypertension[J].Chin J Public Health,2022,38(2):172-176.
[16] 张周斌,薛振香,陈海燕,等.新疆喀什地区维吾尔族人群高血压流行现状及危险因素分析[J].中华流行病学杂志,2017,38(6):709-714.
ZHANG Z B,XUE Z X,CHEN H Y,et al.Prevalence of hypertension and risk factors in Uygur population in Kashgar area of Xinjiang Uygur Autonomous Region[J].Chin J Epidemiol,2017,38(6):709-714.
[17] 马建军,高静,罗俊一,等.新疆阿克苏地区维吾尔族35岁以上人群血脂异常患病率、知晓率、治疗率及控制率的调查研究[J].中国动脉硬化杂志,2016,24(10):1050-1054.
MA J J,GAO J,LUO J Y,et al.The prevalence, awareness rate, treatment rate and control rate of dyslipidemia among Uygur people over 35 years old in Aksu of Xinjiang[J].Chin J Arterioscler,2016,24(10):1050-1054.
[18] 杨娟,郑晓,候丽红,等.太原市老年人多重慢病患病现状及影响因素[J].中华疾病控制杂志,2021,25(1):78-83,107.
YANG J,ZHENG X,HOU L H,et al.The prevalence and influencing factors of multiple chronic diseases in the elderly in Taiyuan[J].Chin J Dis Control,2021,25(1):78-83,107.
[1] 高慧, 谢亮, 姚春阳, 王林红, 金鎏, 胡洁. 血脂异常患者社区综合管理模式的干预效果评价[J]. 预防医学, 2026, 38(1): 15-19.
[2] 吴成慧, 彭艳红, 张可, 朱维晔, 邓亮, 谭玲玲, 瞿丹丹, 米秋香. 中青年2型糖尿病患者益处发现的影响因素分析[J]. 预防医学, 2026, 38(1): 31-35.
[3] 郭艳强, 张丽, 张兰, 韩荣荣. 高血压患者肥胖类型与动脉粥样硬化性心血管疾病风险的关系研究[J]. 预防医学, 2026, 38(1): 36-42.
[4] 贾梦涵, 陈培, 李鑫, 孙玲. 食品环境与肥胖的相关性研究进展[J]. 预防医学, 2026, 38(1): 43-47.
[5] 高雷, 叶真, 王玮, 赵栋, 徐沛维, 章荣华. 生命早期肥胖原暴露与儿童肥胖关系的研究进展[J]. 预防医学, 2026, 38(1): 48-54.
[6] 王芸, 申赟魁, 刘博昊, 陈静, 张琨. 延庆区中小学生近视与超重肥胖共患现况调查[J]. 预防医学, 2026, 38(1): 85-88.
[7] 陆杰, 张柯, 吴雅, 王玥, 张玥, 陆叶, 吴周理, 任志华, 黄艺文. 肥胖指标预测2型糖尿病患者心脑血管疾病的效果比较[J]. 预防医学, 2025, 37(9): 886-891.
[8] 张一, 李梦迪, 石亚锋, 苗超. 余姚市中小学生超重和肥胖现况调查[J]. 预防医学, 2025, 37(9): 955-958.
[9] 周梦怡, 苏丹婷, 何梦洁, 徐沛维, 韩丹, 黄李春, 章荣华. 植物性饮食与不同肥胖类型的关联研究[J]. 预防医学, 2025, 37(8): 773-778.
[10] 张凯慧, 李婉玲, 王彦兴, 安愿. 老年2型糖尿病患者心理灵活性、运动自我效能在衰弱与社会疏离间的中介效应分析[J]. 预防医学, 2025, 37(8): 783-788.
[11] 刘明坤, 张丰香, 韩彩静, 王霞, 陈世坤, 金梅, 孙金月. 2型糖尿病患者周围神经病变风险预测模型研究[J]. 预防医学, 2025, 37(7): 692-696.
[12] 孟杨, 万金豹, 吴萃, 陈秋艳, 严青华, 程旻娜. 上海市农村高血压患者高血压知信行及家庭血压测量调查[J]. 预防医学, 2025, 37(7): 737-742.
[13] 黄阳梅, 沈旭娟, 谢董颖, 张琦, 郑子聪, 王勐. 小学生体重监测信息反馈干预的效果评价[J]. 预防医学, 2025, 37(6): 541-545.
[14] 俞丹丹, 杨加丽, 张雅萍, 许慧琳, 何丹丹, 李俊. 2型糖尿病共病患者空腹血糖波动轨迹的影响因素研究[J]. 预防医学, 2025, 37(6): 562-567,572.
[15] 李美琳, 周梦姣, 吴佳芸, 喻喆, 孔利萍. 老年男性2型糖尿病患者合并肌少症的影响因素分析[J]. 预防医学, 2025, 37(6): 588-592.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed